Chemoinformaics analysis of Allyl methyl tetrasulfide
| Molecular Weight | 184.376 | nRot | 5 |
| Heavy Atom Molecular Weight | 176.312 | nRig | 1 |
| Exact Molecular Weight | 183.951 | nRing | 0 |
| Solubility: LogS | -4.781 | nHRing | 0 |
| Solubility: LogP | 1.725 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 23.6143 |
| nHD | 0 | BPOL | 10.4857 |
| QED | 0.364 |
| Synth | 4.306 |
| Natural Product Likeliness | 2.356 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.759 |
| MDCK | 0.0000227 |
| BBB | 0.961 |
| PPB | 0.644971 |
| VDSS | 0.938 |
| FU | 0.189225 |
| CYP1A2-inh | 0.936 |
| CYP1A2-sub | 0.908 |
| CYP2c19-inh | 0.989 |
| CYP2c19-sub | 0.853 |
| CYP2c9-inh | 0.901 |
| CYP2c9-sub | 0.806 |
| CYP2d6-inh | 0.118 |
| CYP2d6-sub | 0.771 |
| CYP3a4-inh | 0.076 |
| CYP3a4-sub | 0.374 |
| CL | 10.059 |
| T12 | 0.124 |
| hERG | 0.189 |
| Ames | 0.845 |
| ROA | 0.694 |
| SkinSen | 0.966 |
| Carcinogencity | 0.352 |
| EI | 0.995 |
| Respiratory | 0.987 |
| NR-Aromatase | 0.076 |
| Antiviral | No |
| Prediction | 0.9451 |